Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
08 2020
Historique:
received: 17 07 2019
accepted: 24 10 2019
pubmed: 28 10 2019
medline: 28 4 2021
entrez: 26 10 2019
Statut: ppublish

Résumé

Detection of minimal disseminated disease is a validated prognostic factor in ALK-positive anaplastic large cell lymphoma. We previously reported that quantification of minimal disease by quantitative real-time polymerase chain reaction (RQ-PCR) in bone marrow applying a cut-off of 10 copies

Identifiants

pubmed: 31649129
pii: haematol.2019.232314
doi: 10.3324/haematol.2019.232314
pmc: PMC7395281
doi:

Substances chimiques

Anaplastic Lymphoma Kinase EC 2.7.10.1
Protein-Tyrosine Kinases EC 2.7.10.1
Receptor Protein-Tyrosine Kinases EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2141-2149

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

J Clin Oncol. 2009 Oct 20;27(30):5056-61
pubmed: 19738127
Cancer. 2005 Nov 15;104(10):2133-40
pubmed: 16211546
Biol Blood Marrow Transplant. 2010 Feb;16(2):223-30
pubmed: 19800015
Leukemia. 2006 Nov;20(11):1925-30
pubmed: 16990771
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9236-41
pubmed: 10430926
N Engl J Med. 2011 Feb 24;364(8):775-6
pubmed: 21345110
Lancet Oncol. 2013 May;14(6):472-80
pubmed: 23598171
Br J Haematol. 2005 Dec;131(5):624-7
pubmed: 16351638
Blood. 1998 Nov 15;92(10):3591-8
pubmed: 9808552
Br J Haematol. 2017 May;177(4):588-596
pubmed: 28419517
Pediatr Blood Cancer. 2018 Apr;65(4):
pubmed: 29193772
Leukemia. 2012 Oct;26(10):2172-5
pubmed: 22504141
Br J Haematol. 2016 Aug;174(4):541-9
pubmed: 27172403
PLoS One. 2008 Aug 06;3(8):e2876
pubmed: 18682853
N Engl J Med. 2016 Jan 7;374(1):95-6
pubmed: 26736010
Br J Haematol. 2002 Jun;117(4):812-20
pubmed: 12060115
Blood. 2008 Oct 15;112(8):3330-8
pubmed: 18684859
Leuk Res. 2014 May;38(5):581-5
pubmed: 24630366
Blood. 2007 Jul 15;110(2):670-7
pubmed: 17392503
Br J Cancer. 2013 Dec 10;109(12):3084-91
pubmed: 24149177
Blood. 2001 Jun 15;97(12):3699-706
pubmed: 11389005
J Clin Oncol. 2009 Feb 20;27(6):897-903
pubmed: 19139435
Ann Intern Med. 2016 Oct 18;165(8):607-608
pubmed: 27750310
Leukemia. 2019 Aug;33(8):1910-1922
pubmed: 30858550
Leukemia. 2009 Feb;23(2):400-2
pubmed: 18615104
Br J Haematol. 2015 Feb;168(4):557-63
pubmed: 25312752
Clin Chem. 2013 Jun;59(6):892-902
pubmed: 23570709
Eur J Haematol. 2018 Sep;101(3):291-296
pubmed: 29691899
Leukemia. 2013 Feb;27(2):416-22
pubmed: 22907048
J Clin Oncol. 2017 Oct 1;35(28):3215-3221
pubmed: 28787259
PLoS One. 2013 Sep 20;8(9):e75296
pubmed: 24073259
Leukemia. 2015 Feb;29(2):369-76
pubmed: 25036192
J Clin Oncol. 2012 Jun 20;30(18):2190-6
pubmed: 22614995
Bone Marrow Transplant. 2015 Jun;50(6):795-801
pubmed: 25822227
Br J Haematol. 2006 Apr;133(2):176-82
pubmed: 16611309
Int J Hematol. 2018 Feb;107(2):244-250
pubmed: 29030834
J Mol Diagn. 2014 Mar;16(2):174-9
pubmed: 24389534
Lancet Haematol. 2018 Oct;5(10):e450-e461
pubmed: 30290902
PLoS One. 2013;8(3):e58177
pubmed: 23472156
Clin Chem. 2015 Jan;61(1):79-88
pubmed: 25338683
Leukemia. 2005 Sep;19(9):1643-7
pubmed: 16049513
J Natl Cancer Inst. 2014 Feb;106(2):djt378
pubmed: 24491302
Blood. 2006 Jul 1;108(1):28-37
pubmed: 16522812
Science. 1994 Mar 4;263(5151):1281-4
pubmed: 8122112
N Engl J Med. 2003 Oct 9;349(15):1423-32
pubmed: 14534335
Blood. 2014 Jan 16;123(3):334-7
pubmed: 24297868
Br J Haematol. 2009 Aug;146(3):306-9
pubmed: 19545284
J Clin Oncol. 2011 Dec 10;29(35):4669-76
pubmed: 22084369

Auteurs

Christine Damm-Welk (C)

NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Giessen, Germany c.damm-welk@uke.de.

Nina Kutscher (N)

NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Giessen, Germany.

Martin Zimmermann (M)

Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.

Andishe Attarbaschi (A)

Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.

Jutta Schieferstein (J)

NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Giessen, Germany.

Fabian Knörr (F)

Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Ilske Oschlies (I)

Institute of Pathology, Hematopathology Section and Lymph Node Registry, Kiel, Germany.

Wolfram Klapper (W)

Institute of Pathology, Hematopathology Section and Lymph Node Registry, Kiel, Germany.

Wilhelm Woessmann (W)

NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Giessen, Germany w.woessmann@uke.de.
Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH